Antibody Category
Suppliers
Applications
Antibody Types
Host Species
Species Reactivity
  • Category A

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category B

    • Original source/host: Animal (historic hybridoma) OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    • Recombinantly reformatted hybridomas are included as they align with the May 2020 EURL ECVAM recommendation, which permits continued use of existing, sequenced, and well-characterised hybridomas to produce recombinant monoclonal antibodies in vitro, as animals are no longer directly involved
    • Naïve, non-immunised animal B cell-derived in vitro antibody display libraries align with the May 2020 EURL ECVAM recommendation to no longer authorise the development and production of antibodies through animal immunisation
    Search
  • Category C

    • Original source/host: Naïve (human-derived B cell) or synthetic, natural or consensus framework (any species, published framework sequences) antibody or mimetic
    • Discovery method: Non-immunisation based in vitro display selection of antibody or mimetic
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category D

    • Original source/host: Animal OR naïve, non-immunised animal B cell-derived in vitro antibody display library
    • Discovery method: immunisation pre-2020 OR in vitro display selection of antibodies
    • Production: Recombinant expression ; animal-derived biomaterials used in production or final formulation
    Search
  • Category E

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search
  • Category F

    • Original source/host: Animal
    • Discovery method: immunisation-based selection post 2020
    • Production: Recombinant expression with animal-derived biomaterials used in production or final formulation
    Search
  • Category G

    • Original source/host: Unknown
    • Discovery method: Unknown
    • Production: Recombinant expression with no use of animal-derived biomaterials in production or final formulation
    Search

ROR1 Antibody


Biorbyt logo
View Antibody details

ROR1 Antibody


Biorbyt logo
View Antibody details

ROR2 Antibody


Biorbyt logo
View Antibody details

ROR2 Antibody


Biorbyt logo
View Antibody details

Rosmantuzumab Biosimilar – Anti-RSPO3 mAb – Research Grade


Proteo Genix logo
View Antibody details

Rosnilimab Biosimilar – Anti-PDCD1 mAb – Research Grade


Proteo Genix logo
View Antibody details

Rosopatamab Biosimilar – Anti-FOLH1 mAb – Research Grade


Proteo Genix logo
View Antibody details

Rovalpituzumab Biosimilar – Anti-DLL3 mAb – Research Grade


Proteo Genix logo
View Antibody details

Rovelizumab Biosimilar – Anti-ITGAL/ CD11a/ ITGB2/ CD18 mAb – Research Grade


Proteo Genix logo
View Antibody details

Rozanolixizumab Biosimilar – Anti-FCGRT mAb – Research Grade


Proteo Genix logo
View Antibody details